Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for tyrosine in Any Name (approximate match)

Showing 291 - 300 of 581 results

First page
Previous page
Next page
Next page

ZILOVERTAMAB VEDOTIN

IZY9ZSI6FI

Subunit 1 (446) Similarity Search Subunit 2 (446) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (214) Similarity Search

Sequence Search

Subunit 1 (446) Similarity Search Subunit 2 (446) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (214) Similarity Search

Status:

Investigational

Source:

INN:zilovertamab vedotin [INN]

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/IZY9ZSI6FI

Class:

PROTEIN

BATIRAXCEPT

B6840JH4EB

Subunit 1 (426) Similarity Search Subunit 2 (426) Similarity Search

Sequence Search

Subunit 1 (426) Similarity Search Subunit 2 (426) Similarity Search

Status:

Investigational

Source:

NCT04019288: Phase 1/Phase 2 Interventional Completed Platinum-Resistant Fallopian Tube Carcinoma

(2019)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT04019288

Class:

PROTEIN

TILVESTAMAB

IZK2TH7X5M

Subunit 1 (448) Similarity Search Subunit 2 (448) Similarity Search Subunit 3 (219) Similarity Search Subunit 4 (219) Similarity Search

Sequence Search

Subunit 1 (448) Similarity Search Subunit 2 (448) Similarity Search Subunit 3 (219) Similarity Search Subunit 4 (219) Similarity Search

Status:

Investigational

Source:

NCT03795142: Early Phase 1 Interventional Completed Healthy Volunteers

(2018)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03795142

Class:

PROTEIN

FLT-3 LIGAND PROTEIN (MAMMALIAN GLYCOSYLATION)

6S1KJ9KP8S

Subunit 1 (209) Similarity Search Subunit 2 (209) Similarity Search

Sequence Search

Subunit 1 (209) Similarity Search Subunit 2 (209) Similarity Search

Status:

Investigational

Source:

NCT00003431: Phase 1 Interventional Completed Colorectal Cancer

(1998)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT00003431

Class:

PROTEIN

Disitamab

474FJM6Y9C

Subunit 1 (445) Similarity Search Subunit 2 (445) Similarity Search Subunit 3 (212) Similarity Search Subunit 4 (212) Similarity Search

Sequence Search

Subunit 1 (445) Similarity Search Subunit 2 (445) Similarity Search Subunit 3 (212) Similarity Search Subunit 4 (212) Similarity Search

Status:

Investigational

Source:

INN:disitamab [INN]

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/474FJM6Y9C

Class:

PROTEIN

AVIZAKIMAB

4H3BBE5WVK

Subunit 1 (446) Similarity Search Subunit 2 (446) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (214) Similarity Search

Sequence Search

Subunit 1 (446) Similarity Search Subunit 2 (446) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (214) Similarity Search

Status:

Investigational

Source:

NCT03371251: Phase 1/Phase 2 Interventional Completed Systemic Lupus Erythematosus

(2018)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03371251

Class:

PROTEIN

Davoceticept

DE9GN7CD21

Subunit 1 (345) Similarity Search Subunit 2 (345) Similarity Search

Sequence Search

Subunit 1 (345) Similarity Search Subunit 2 (345) Similarity Search

Status:

Investigational

Source:

INN:davoceticept [INN]

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/DE9GN7CD21

Class:

PROTEIN

MECBOTAMAB VEDOTIN

VF40YVX65F

Subunit 1 (449) Similarity Search Subunit 2 (449) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (214) Similarity Search

Sequence Search

Subunit 1 (449) Similarity Search Subunit 2 (449) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (214) Similarity Search

Status:

Investigational

Source:

INN:mecbotamab vedotin [INN]

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/VF40YVX65F

Class:

PROTEIN

Bafisontamab

G86X5QQ7M5

Subunit 1 (663) Similarity Search Subunit 2 (663) Similarity Search Subunit 3 (220) Similarity Search Subunit 4 (220) Similarity Search Subunit 5 (214) Similarity Search Subunit 6 (214) Similarity Search

Sequence Search

Subunit 1 (663) Similarity Search Subunit 2 (663) Similarity Search Subunit 3 (220) Similarity Search Subunit 4 (220) Similarity Search Subunit 5 (214) Similarity Search Subunit 6 (214) Similarity Search

Status:

Investigational

Source:

NCT03797391: Phase 1/Phase 2 Interventional Recruiting Neoplasms

(2018)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03797391

Class:

PROTEIN

Disitamab Vedotin

RB3U3A1S27

Subunit 1 (445) Similarity Search Subunit 2 (445) Similarity Search Subunit 3 (212) Similarity Search Subunit 4 (212) Similarity Search

Sequence Search

Subunit 1 (445) Similarity Search Subunit 2 (445) Similarity Search Subunit 3 (212) Similarity Search Subunit 4 (212) Similarity Search

Status:

Investigational

Source:

NCT03500380: Phase 2/Phase 3 Interventional Active, not recruiting Breast Neoplasms

(2018)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03500380

Class:

PROTEIN

Protein

ZILOVERTAMAB VEDOTIN

Protein

Protein

Protein

FLT-3 LIGAND PROTEIN (MAMMALIAN GLYCOSYLATION)

Protein

Protein

Protein

Protein

MECBOTAMAB VEDOTIN

Protein

Protein

Disitamab Vedotin

Showing 291 - 300 of 581 results

First page
Previous page
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1